Block listing Interim Review

Hikma Pharmaceuticals Plc
02 October 2023
 

Hikma Pharmaceuticals PLC

 

 

 

 

Block Listing Six Monthly Return

 

Date: 2 October 2023

 

Name of applicant:

Hikma Pharmaceuticals PLC

Name of scheme:

Hikma Pharmaceuticals PLC 2018 Management Incentive Plan ("2018 MIP") and Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP") (together "the Plans")

Period of return

From: 1 April 2023

To:

30 September 2023

Balance of unallotted securities under scheme(s) from previous return:

The Plans: 1,497,913 Ordinary Shares of 10 pence

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

The Plans: 0 Ordinary Shares of 10 pence

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

2018 MIP: 438 Ordinary Shares of 10 pence

EIP: 378,765 Ordinary Shares of 10 pence

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

The Plans: 1,118,710 Ordinary Shares of 10 pence

 

Name of contact:

Hussein Arkhagha

Telephone number of contact:

+44(0)20 7399 2760

 

LEI: 549300BNS685UXH4JI75

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings